Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE)
SAM.GOV Due: December 12, 2024 at 07:00 PM UTC
In-Active Presolicitation Source Url

Summary

The Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) opportunity, issued by the Advanced Research Projects Agency for Health (ARPA-H), aims to foster innovative solutions targeting the lymphatic system, particularly in addressing both rare and chronic disorders. This presolicitation invites contractors with expertise in health sciences, particularly those specializing in lymphatic interventions and drug development, to submit proposals that demonstrate scientific and technical merit. The program emphasizes collaboration with patient advocates and requires proposers to include patients as key team members. Eligible businesses should be prepared to engage in a rigorous evaluation process that includes submitting a Solution Summary and potentially a Full Proposal following a Pre-Award Pitch Presentation.
Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
541714
Set Aside
None
Place of Performance
Washington , District of Columbia
Point of Contact
Full Name Email Phone Type
The GLIDE Team [email protected] None primary
Attachments
  • GLIDE+ISO+ARPA-H-SOL-24-111+Amendment+2+-+6+DEC+2024.pdf
  • GLIDE+FAQ+20250115.pdf
  • Attachment+3a.+-+ARPA-H+COST+PROPOSAL+SPREADSHEET+%28Cooperative+Agreement%29.xlsx
  • Attachment+3b.+-+ARPA-H+COST+PROPOSAL+SPREADSHEET+%28Other+Transaction%29.xlsx
  • Attachment+2.+-+GLIDE_Pitch+Template+v1.2.pptx
  • Attachment+1.+-+GLIDE+TPP+Template+and+Examples.docx